A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment

Brain Imaging and Behavior

Volumn 6, Issue 4, 2012, Pages 517-527

  Gibbons, Laura E ^a   Carle, Adam C ^b   Mackin, R Scott ^c   Harvey, Danielle ^d   Mukherjee, Shubhabrata ^a   Insel, Philip ^c   Curtis, S McKay ^a   Mungas, Dan ^e   Crane, Paul K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Composite scores; Executive function; Item response theory; Mild cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

AGED; ALZHEIMERS DISEASE NEUROIMAGING INITIATIVE; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARS TRIANGULARIS; PREDICTION; PRIORITY JOURNAL; PSYCHOMETRY; WHITE MATTER;

EID: 84871722944     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-012-9176-1     Document Type: Article

References (45)

1. Alvarez, J. A., & Emory, E. (2006). Executive function and the frontal lobes: a meta-analytic review. Neuropsychology Review, 16(1), 17-42. doi: 10. 1007/s11065-006-9002-x.
2. Baker, F. B., & Kim, S.-H. (2004). Item response theory: Parameter estimation techniques (2nd ed.). New York: CRC Press.
3. Cahn-Weiner, D. A., Boyle, P. A., & Malloy, P. F. (2002). Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Applied Neuropsychology, 9(3), 187-191. doi: 10. 1207/S15324826AN0903_8.
4. Cardenas, V. A., Chao, L. L., Studholme, C., Yaffe, K., Miller, B. L., Madison, C., et al. (2011). Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiology of Aging, 32(4), 572-580. doi: 10. 1016/j. neurobiolaging. 2009. 04. 011.
5. Carmichael, O., Mungas, D., Beckett, L., Harvey, D., Tomaszewski Farias, S., Reed, B., et al. (2010). MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiology of Aging. doi: 10. 1016/j. neurobiolaging. 2010. 01. 021.
6. Carmichael, O., Schwarz, C., Drucker, D., Fletcher, E., Harvey, D., Beckett, L., et al. (2010). Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Archives of Neurology, 67(11), 1370-1378. doi: 10. 1001/archneurol. 2010. 284.
7. Chang, Y. L., Jacobson, M. W., Fennema-Notestine, C., Hagler, D. J., Jr., Jennings, R. G., Dale, A. M., et al. (2010). Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness. Cerebral Cortex, 20(6), 1305-1313. doi: 10. 1093/cercor/bhp192.
8. Crane, P. K., Narasimhalu, K., Gibbons, L. E., Pedraza, O., Mehta, K. M., Tang, Y., et al. (2008). Composite scores for executive function items: demographic heterogeneity and relationships with quantitative magnetic resonance imaging. Journal of the International Neuropsychological Society: JINS, 14(5), 746-59. doi: 10. 1017/S1355617708081162.
9. De Meyer, G., Shapiro, F., Vanderstichele, H., Vanmechelen, E., Engelborghs, S., De Deyn, P. P., et al. (2010). Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Archives of Neurology, 67(8), 949-956. doi: 10. 1001/archneurol. 2010. 179.
10. Ewers, M., Walsh, C., Trojanowski, J. Q., Shaw, L. M., Petersen, R. C., Jack, C. R., Jr., et al. (2010). Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiology of Aging. doi: 10. 1016/j. neurobiolaging. 2010. 10. 019.
11. Farias, S. T., Mungas, D., Reed, B. R., Harvey, D., & DeCarli, C. (2009). Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Archives of Neurology, 66(9), 1151-1157. doi: 10. 1001/archneurol. 2009. 106.
12. Farias, S. T., Mungas, D., Reed, B., Carmichael, O., Beckett, L., Harvey, D., et al. (2011). Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology. Neurobiology of Aging. doi: 10. 1016/j. neurobiolaging. 2011. 03. 017.
13. Gomar, J. J., Bobes-Bascaran, M. T., Conejero-Goldberg, C., Davies, P., & Goldberg, T. E. (2011). Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Archives of General Psychiatry, 68(9), 961-969. doi: 10. 1001/archgenpsychiatry. 2011. 96.
14. Goodglass, H., & Kaplan, D. (1983). The assessment of aphasia and related disorders (2nd ed.). Philadelphia: Lea & Febiger.
15. Grambaite, R., Selnes, P., Reinvang, I., Aarsland, D., Hessen, E., Gjerstad, L., et al. (2011). Executive Dysfunction in Mild Cognitive Impairment is Associated with Changes in Frontal and Cingulate White Matter Tracts. Journal of Alzheimer's Disease: JAD. doi: 10. 3233/JAD-2011-110290.
16. Jack, C. R., Jr., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., et al. (2008). The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging, 27(4), 685-691. doi: 10. 1002/jmri. 21049.
17. Jack, C. R., Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, 9(1), 119-128. doi: 10. 1016/S1474-4422(09)70299-6.
18. Li, Y., Bolt, D. M., & Fu, J. (2006). A comparison of alternative models for testlets. Applied Psychological Measurement, 30(1), 3-21.
19. Llano, D. A., Laforet, G., & Devanarayan, V. (2011). Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease. Alzheimer Disease and Associated Disorders, 25(1), 73-84. doi: 10. 1097/WAD. 0b013e3181f5b8d8.
20. Marra, C., Ferraccioli, M., Vita, M. G., Quaranta, D., & Gainotti, G. (2011). Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI. Current Alzheimer Research, 8(1), 24-31.
21. McDonald, R. P. (1999). Test theory: a unified treatment. Mahwah: Lawrence Erlbaum.
22. McDonald, C. R., Gharapetian, L., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., Jr., Holland, D., et al. (2010). Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiology of Aging. doi: 10. 1016/j. neurobiolaging. 2010. 03. 015.
23. Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T. D. (2000). The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cognit Psychol, 41(1), 49-100.
24. Mohs, R. C., Knopman, D., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., et al. (1997). Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders, 11(Suppl 2), S13-21.
25. Morris, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., et al. (1989). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39(9), 1159-1165.
26. Mungas, D., Harvey, D., Reed, B. R., Jagust, W. J., DeCarli, C., Beckett, L., et al. (2005). Longitudinal volumetric MRI change and rate of cognitive decline. Neurology, 65(4), 565-571. doi: 10. 1212/01. wnl. 0000172913. 88973. 0d.
27. Mungas, D., Beckett, L., Harvey, D., Farias, S. T., Reed, B., Carmichael, O., et al. (2010). Heterogeneity of cognitive trajectories in diverse older persons. Psychology and Aging, 25(3), 606-619. doi: 10. 1037/a0019502.
28. Muthén, L. K., & Muthén, B. O. (1998-2007). Mplus: statistical analysis with latent variables. (5. 1 ed.). Los Angeles, CA: Muthén & Muthén.
29. Nordlund, A., Rolstad, S., Klang, O., Lind, K., Pedersen, M., Blennow, K., et al. (2008). Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. Journal of the International Neuropsychological Society: JINS, 14(4), 582-590. doi: 10. 1017/S135561770808079X.
30. Nordlund, A., Rolstad, S., Gothlin, M., Edman, A., Hansen, S., & Wallin, A. (2010). Cognitive profiles of incipient dementia in the Goteborg MCI study. Dementia and Geriatric Cognitive Disorders, 30(5), 403-410. doi: 10. 1159/000321352.
31. Parks, C. M., Iosif, A. M., Farias, S., Reed, B., Mungas, D., & DeCarli, C. (2011). Executive function mediates effects of white matter hyperintensities on episodic memory. Neuropsychologia, 49(10), 2817-2824. doi: 10. 1016/j. neuropsychologia. 2011. 06. 003.
32. Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., et al. (2010). Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology, 74(3), 201-209. doi: 10. 1212/WNL. 0b013e3181cb3e25.
33. Reeve, B. B., Hays, R. D., Bjorner, J. B., Cook, K. F., Crane, P. K., Teresi, J. A., et al. (2007). Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Medical Care, 45(5 Suppl 1), S22-31.
34. Reitan, R. M., & Wolfson, D. (1985). The Halstead-Reitan neuropsychological test battery. Tucson: Neuropsychology Press.
35. Rolstad, S., Berg, A. I., Bjerke, M., Blennow, K., Johansson, B., Zetterberg, H., et al. (2011). Amyloid-beta is associated with cognitive impairment in healthy elderly and subjective cognitive impairment. Journal of Alzheimer's Disease: JAD, 26(1), 135-142. doi: 10. 3233/JAD-2011-110038.
36. Salthouse, T. A. (2005). Relations between cognitive abilities and measures of executive functioning. Neuropsychology, 19(4), 532-545.
37. Schwarz, C., Fletcher, E., DeCarli, C., & Carmichael, O. (2009). Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. Information Processing in Medical Imaging, 21, 239-251.
38. Shaw, L. M., Vanderstichele, H., Knapik-Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., et al. (2009). Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology, 65(4), 403-413. doi: 10. 1002/ana. 21610.
39. Smith, E. E., Salat, D. H., Jeng, J., McCreary, C. R., Fischl, B., Schmahmann, J. D., et al. (2011). Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology, 76(17), 1492-1499. doi: 10. 1212/WNL. 0b013e318217e7c8.
40. StataCorp. (2011). Stata statistical software: release 12. College Station: StataCorp LP.
41. Tabert, M. H., Manly, J. J., Liu, X., Pelton, G. H., Rosenblum, S., Jacobs, M., et al. (2006). Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Archives of General Psychiatry, 63(8), 916-924. doi: 10. 1001/archpsyc. 63. 8. 916.
42. Trojanowski, J. Q., Vandeerstichele, H., Korecka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., et al. (2010). Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 6(3), 230-238. doi: 10. 1016/j. jalz. 2010. 03. 008.
43. Wainer, H., Bradlow, E. T., & Wang, X. (2007). Testlet response theory and its applications. NY: Cambridge UP.
44. Wechsler, D. (1981). Wechsler adult intelligence scale-revised. San Antonio: Psychological Corporation.
45. Wechsler, D. (1987). Wechsler memory scale-revised. San Antonio: Psychological Corporation.